InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Goddard Glenn, Chief Financial Officer. Director active across 1 company, notably Intellia Therapeutics, Inc.. In total, 10 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €230k. Activity tracked since 5 August 2021. The latest transaction was disclosed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Goddard Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
28,628 shares0Common StockSEC:0000950170-24-025901:0
5,365 shares@ US$29.4612.7% of flowCommon StockSEC:0000950170-24-002511:0
3,062 sharesCommon StockSEC:0000950170-24-001173:0
27,484 shares0Common StockSEC:0001209191-23-015776:0
2,427 shares@ US$37.217.5% of flowCommon StockSEC:0001209191-23-002414:0
3,062 sharesCommon StockSEC:0001209191-23-001490:0
3,062 sharesCommon StockSEC:0001209191-22-015917:0
3,482 shares@ US$14.586.3% of flowCommon StockSEC:0001209191-21-055347:0
5,200 shares@ US$19.2712.4% of flowCommon StockSEC:0001209191-21-054315:0
20,000 shares@ US$19.2747.6% of flowCommon StockSEC:0001209191-21-050225:0
10 of 10 declarations
About Goddard Glenn
Goddard Glenn is Directeur Financier at Intellia Therapeutics, Inc. (EVP, Chief Financial Officer). Across the 10 filings recorded, the sampled filings cover the period from 2021-08-06 to 2024-03-05, with EUR 230075 of sales and EUR 0 of purchases, and the modal transaction nature is Option exercise.
